Identification and validation of biomarkers for autism spectrum disorders

Nature Reviews Drug Discovery

Volumn 15, Issue 1, 2016, Pages 70-73

  Loth, Eva ^a   Spooren, Will ^b   Ham, Lindsay M ^b   Isaac, Maria B ^b   Auriche Benichou, Caroline ^b   Banaschewski, Tobias ^b   Baron Cohen, Simon ^b   Broich, Karl ^b   Bolte, Sven ^b   Bourgeron, Thomas ^b   Charman, Tony ^b   Collier, David ^b   de Andres Trelles, Fernando ^b   Durston, Sarah ^b   Ecker, Christine ^b   Elferink, Andre ^b   Haberkamp, Marion ^b   Hemmings, Robert ^b   Johnson, Mark H ^b   Jones, Emily J H ^b   Khwaja, Omar S ^b   Lenton, Sabine ^b   Mason, Luke ^b   Mantua, Valentina ^b   Meyer Lindenberg, Andreas ^b   Lombardo, Michael V ^b   O'Dwyer, Laurence ^b   Okamoto, Koichi ^b   Pandina, Gahan J ^b   Pani, Luca ^b   Persico, Antonio M ^b   Simonoff, Emily ^b   Tauscher Wisniewski, Sitra ^b   Llinares Garcia, Jordi ^b   Vamvakas, Spiros ^b   Williams, Steve ^b   Buitelaar, Jan K ^b   Murphy, Declan G M ^b   more..

^a KING'S COLLEGE LONDON   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; BIOLOGICAL MARKER;

ADAPTIVE BEHAVIOR; AUTISM; BEHAVIOR DISORDER; BRAIN FUNCTION; COGNITION; COMMUNICATION DISORDER; COMORBIDITY; DRUG INDUSTRY; DRUG TARGETING; ELECTROENCEPHALOGRAM; EYE TRACKING; HUMAN; INTELLECTUAL IMPAIRMENT; LETTER; MULTIVARIATE ANALYSIS; NEUROIMAGING; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PATIENT CODING; PATIENT SELECTION; PRIORITY JOURNAL; QUALITY OF LIFE; SENSORY DYSFUNCTION; SYMPTOM; ADOLESCENT; ADULT; CHILD; ENDOPHENOTYPE; FEMALE; MALE; METABOLISM; PRESCHOOL CHILD; REPRODUCIBILITY; YOUNG ADULT;

ADOLESCENT; ADULT; AUTISM SPECTRUM DISORDER; BIOMARKERS; CHILD; CHILD, PRESCHOOL; ENDOPHENOTYPES; FEMALE; HUMANS; MALE; REPRODUCIBILITY OF RESULTS; YOUNG ADULT;

EID: 84954461829     PISSN: 14741776     EISSN: 14741784     Source Type: Journal    
DOI: 10.1038/nrd.2015.7     Document Type: Letter

References (10)

1. Ghosh, A., Michalon, A., Lindemann, L., Fontoura, P. & Santarelli, L. Drug discovery for autism spectrum disorder: challenges and opportunities. Nat. Rev. Drug Discov. 12, 777-790 (2013).
2. Murphy, D. & Spooren, W. EU AIMS: a boost to autism research. Nat. Rev. Drug Discov. 11, 815-816 (2012).
3. Simonoff, E. et al. Psychiatric disorders in children with autism spectrum disorders: prevalence, comorbidity, and associated factors in a population-derived sample. J. Am. Acad. Child Adolesc. Psychiatry 47, 921-929 (2008).
4. Charman, T. et al. IQ in children with autism spectrum disorders: data from the Special Needs and Autism Project (SNAP). Psychol. Med. 41, 619-627 (2011).
5. Cuthbert, B. N. & Insel, T. R. Toward the future of psychiatric diagnosis: the seven pillars of RDoC. BMC Med. 11, 126 (2013).
6. Buitelaar, J. K., Wilens, T. E., Zhang, S., Ning, Y. & Feldman, P. D. Comparison of symptomatic versus functional changes in children and adolescents with ADHD during randomized, double-blind treatment with psychostimulants, atomoxetine, or placebo. J. Child Psychol. Psychiatry 50, 335-342 (2009).
7. Lai, M. C., Lombardo, M. V., Auyeung, B., Chakrabarti, B. & Baron-Cohen, S. Sex/gender differences and autism: setting the scene for future research. J. Am. Acad. Child Adolesc. Psychiatry 54, 11-24 (2015).
8. Ecker, C. et al. Investigating the predictive value of whole-brain structural MR scans in autism: a pattern classification approach. Neuroimage 49, 44-56 (2010).
9. Lombardo, M. V. et al. Different functional neural substrates for good and poor language outcome in autism. Neuron 86, 567-577 (2015).
10. Daly, E. M. et al. Serotonin and the neural processing of facial emotions in adults with autism: an fMRI study using acute tryptophan depletion. Arch. Gen. Psychiatry 69, 1003-1013 (2012).